We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $83M
This Fund
S&P 500
This Quarter Est. Return
-6.18%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
Cap. Flow
+$130M
Cap. Flow %
115.08%
Top 10 Hldgs %
93.32%
Holding
31
New
31
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 65.44%
2 Consumer Discretionary 11.8%
3 Energy 10.94%
4 Industrials 7.74%
5 Materials 3.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XFOR icon
1
X4 Pharmaceuticals
XFOR
$363M
$35.8M 31.57%
+8,951,105
New +$32.5M
IMRX icon
2
Immuneering
IMRX
$278M
$17.6M 15.52%
+2,674,950
New +$17.2M
EMPD
3
Empery Digital
EMPD
$94.7M
$13.4M 11.8%
+2,930,345
New +$17.1M
IMPP icon
4
Imperial Petroleum
IMPP
$219M
$11.5M 10.16%
+3,182,951
New +$15.7M
DTIL icon
5
Precision BioSciences
DTIL
$185M
$9.13M 8.05%
+2,194,635
New +$12.5M
ADUR
6
Aduro Clean Technologies
ADUR
$488M
$5.92M 5.22%
+571,046
New +$7.53M
TNYA icon
7
Tenaya Therapeutics
TNYA
$165M
$3.85M 3.4%
+5,414,101
New +$7.36M
CRML icon
8
Critical Metals Corp
CRML
$867M
$3.41M 3.01%
+491,460
New +$5.36M
EOSE icon
9
Eos Energy Enterprises
EOSE
$1.27B
$2.86M 2.52%
+249,726
New +$3.59M
SRZN icon
10
Surrozen
SRZN
$245M
$2.35M 2.07%
+103,974
New +$1.68M
TLPH icon
11
Talphera
TLPH
$73.2M
$1.52M 1.34%
+1,333,497
New +$1.61M
KZIA
12
Kazia Therapeutics
KZIA
$145M
$1.17M 1.03%
+170,000
New +$1.45M
PROF
13
Profound Medical
PROF
$246M
$1.13M 1%
+143,532
New +$922K
RBNE
14
Robin Energy Ltd
RBNE
$2.11M
$882K 0.78%
+20,071
New +$1.52M
SLE icon
15
Super League Enterprise
SLE
$4.34M
$763K 0.67%
+104,166
New +$2.1M
XLO icon
16
Xilio Therapeutics
XLO
$55.3M
$757K 0.67%
+84,503
New +$888K
BNTC icon
17
Benitec Biopharma
BNTC
$387M
$747K 0.66%
+55,440
New +$767K
BCTXZ
18
BriaCell Therapeutics Corp Warrant
BCTXZ
$232K
$193K 0.17%
+666,600
New +$248K
ALUR
19
DELISTED
Allurion Technologies
ALUR
$73.7K 0.06%
+59,881
New +$101K
TARA icon
20
Protara Therapeutics
TARA
$223M
$68.4K 0.06%
+12,832
New +$71.3K
NTRBW icon
21
Nutriband Inc Warrant
NTRBW
$64.8K 0.06%
+40,218
New +$70.8K
RTACW
22
Renatus Tactical Acquisition Corp I Warrant
RTACW
$8.57M
$40.6K 0.04%
+50,000
New +$57.8K
NRSNW icon
23
NeuroSense Therapeutics Warrant
NRSNW
$1.4M
$36.1K 0.03%
+100,402
New +$35.7K
MTEKW icon
24
Maris-Tech Ltd Warrants
MTEKW
$923K
$35.7K 0.03%
+297,600
New +$52.2K
BNCWW
25
CEA Industries Inc Warrant
BNCWW
$44.7K
$27.6K 0.02%
+500,000
New +$56.3K

Similar funds

Empery Asset Management's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for Empery Asset Management, which disclosed 31 positions worth $113M. Its ten largest holdings account for 93% of the portfolio.

Its largest position is X4 Pharmaceuticals: 8,951,105 shares worth $35.8M.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, followed by Consumer Discretionary and Energy.

  • Empery Asset Management's largest Q4 2025 buy was X4 Pharmaceuticals: 8,951,105 shares worth $35.8M.
  • Empery Asset Management's ten largest holdings make up 93% of its $113M portfolio in Q4 2025.
  • Empery Asset Management disclosed 31 positions in Q4 2025, its first 13F filing on record.

Based on Empery Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.